Drug Regulators
- All
- News
- Videos
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Union Health Ministry Proposes To Remove Duplicate Viral Testing Of Blood Products
The government has issued a draft Gazette Notification proposing amendments to avoid duplicate viral testing of blood products and invited public comments on it, an official statement said on Wednesday.
-
Gujarat Expands Essential Drug List To 1,479; Removes 57 Medicines, Adds 150 New Ones
The Gujarat government has expanded its Essential Drug List (EDL) for 202526 by adding 150 medicines following a review of the existing list, a move aimed at strengthening the availability of free treatment across public
-
Nicotine Gums Need To Be Regulated Better For Those Who Want To Quit Smoking: Experts
In India, nicotine gums fall under Schedule K exemptions of the Drugs and Cosmetics Rules, intended to improve access to essential public health interventions.
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
New Study Links Popular Diabetes Drugs To Reduced Risk Of Strokes
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
-
Chemists' Association Writes To PM Modi Over Concerns Of AI-Generated Fake Prescriptions
In a letter, the chemists' body flagged the growing trend of AI-generated prescriptions, often carrying fictitious hospital names and fabricated patient details, being accepted by certain online platforms.
-
Mexican Drug Cartel Drones Trigger Laser Strike That Shut Down US Airspace
The government's ability to deal with drones that pose a threat on American soil has been questioned this week after the use of a laser designed to shoot down drones near the border in Texas led to the abrupt closure of the airspace over El Paso
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Union Health Ministry Proposes To Remove Duplicate Viral Testing Of Blood Products
The government has issued a draft Gazette Notification proposing amendments to avoid duplicate viral testing of blood products and invited public comments on it, an official statement said on Wednesday.
-
Gujarat Expands Essential Drug List To 1,479; Removes 57 Medicines, Adds 150 New Ones
The Gujarat government has expanded its Essential Drug List (EDL) for 202526 by adding 150 medicines following a review of the existing list, a move aimed at strengthening the availability of free treatment across public
-
Nicotine Gums Need To Be Regulated Better For Those Who Want To Quit Smoking: Experts
In India, nicotine gums fall under Schedule K exemptions of the Drugs and Cosmetics Rules, intended to improve access to essential public health interventions.
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
New Study Links Popular Diabetes Drugs To Reduced Risk Of Strokes
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
-
Chemists' Association Writes To PM Modi Over Concerns Of AI-Generated Fake Prescriptions
In a letter, the chemists' body flagged the growing trend of AI-generated prescriptions, often carrying fictitious hospital names and fabricated patient details, being accepted by certain online platforms.
-
Mexican Drug Cartel Drones Trigger Laser Strike That Shut Down US Airspace
The government's ability to deal with drones that pose a threat on American soil has been questioned this week after the use of a laser designed to shoot down drones near the border in Texas led to the abrupt closure of the airspace over El Paso
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
